EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective

Sanne A J H van de Camp, Lizan Stinissen, Andrew Huseth, Brentney Simon, Jennifer Ryan, Anna Sarkozy, Filip Van Petegem, Michael F Goldberg, Heinz Jungbluth, Johann Böhm, Wija Oortwijn, Robert T Dirksen und 1 weitere

Journal of Neuromuscular Diseases · 2024

DOI: 10.3233/jnd-240029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuromuscular Diseases, 2024. Verfasst von Sanne A J H van de Camp und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands. Hauptthemen laut MEDLINE: Ryanodine Receptor Calcium Release Channel, Quality of Life, Caregivers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and objective: Pathogenic variants of RYR1, the gene encoding the principal sarcoplasmic reticulum calcium release channel (RyR1) with a crucial role in excitation-contraction coupling, are among the most common genetic causes of non-dystrophic neuromuscular disorders. We recently conducted a questionnaire study focusing on functional impairments, fatigue, and quality of life (QoL) in patients with RYR1-related diseases ( RYR1-RD) throughout the recognized disease spectrum. In this previous questionnaire study the medical perspective was taken, reflective of a study protocol designed by neurologists and psychologists. With this present study we wanted to specifically address the patient perspective.

Methods

Together with affected individuals, family members, and advocates concerned with RYR1-RD, we developed an online patient survey that was completed by 227 patients or their parents/other caretakers (143 females and 84 males, 0–85 years). We invited 12 individuals, representing most of the patient group based on age, sex, race, and type and severity of diagnosis, to share their personal experiences on living with a RYR1-RD during an international workshop in July 2022. Data were analyzed through a mixed-methods approach, employing both a quantitative analysis of the survey results and a qualitative analysis of the testimonials.

Results

Data obtained from the combined quantitative and qualitative analyses provide important insights on six topics: 1) Diagnosis; 2) Symptoms and impact of the condition; 3) Physical activity; 4) Treatment; 5) Clinical research and studies; and 6) Expectations.

Conclusions

Together, this study provides a unique patient perspective on the RYR1-RD spectrum, associated disease impact, suitable physical activities and expectations of future treatments and trials, and thus, offers an essential contribution to future research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ryanodine Receptor Calcium Release ChannelQuality of LifeCaregiversHumansMaleFemaleAdultMiddle AgedAdolescentAgedChildYoung AdultSurveys and QuestionnairesAged, 80 and overChild, PreschoolInfantNeuromuscular DiseasesInfant, NewbornFamily

Stichwörter der Autor:innen

Myopathycentral coreglobal burden of diseasemalignant hyperthermiapatient participationqualitative research

Substanzen

Ryanodine Receptor Calcium Release ChannelRYR1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  • The RYR-1 Foundation, Pittsburgh, PA, USA.
  • The Dubowitz Neuromuscular Centre, Great Ormond Street Hospital for Children and Institute of Child Health, London, UK.
  • Department of Biochemistry and Molecular Biology, The Life Sciences Institute, The University of British Columbia, Vancouver, BC, Canada.
  • Department of Paediatric Neurology, Neuromuscular Service, Evelina Children's Hospital, Guy's and St Thomas' Hospital NHS Foundation Trust, London, UK.
  • Randall Centre for Cell and Molecular Biophysics, Muscle Signalling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London, UK.

Förderung

  • NIAMS NIH HHS

Zitieren

APA

van de Camp, S. A. J. H., Stinissen, L., Huseth, A., Simon, B., Ryan, J., Sarkozy, A., Van Petegem, F., Goldberg, M. F., Jungbluth, H., Böhm, J., Oortwijn, W., Dirksen, R. T., & Voermans, N. C. (2024). Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective. Journal of Neuromuscular Diseases. https://doi.org/10.3233/jnd-240029

Vancouver

van de Camp SAJH, Stinissen L, Huseth A, Simon B, Ryan J, Sarkozy A, et al. Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective. Journal of Neuromuscular Diseases. 2024. doi:10.3233/jnd-240029

BibTeX
@article{vandeCamp2024,
  author = {van de Camp, Sanne A J H and Stinissen, Lizan and Huseth, Andrew and Simon, Brentney and Ryan, Jennifer and Sarkozy, Anna and Van Petegem, Filip and Goldberg, Michael F and Jungbluth, Heinz and Böhm, Johann and Oortwijn, Wija and Dirksen, Robert T and Voermans, Nicol C},
  title = {Individuals and Families Affected by RYR1-Related Diseases: The Patient/Caregiver Perspective},
  journal = {Journal of Neuromuscular Diseases},
  year = {2024},
  doi = {10.3233/jnd-240029}
}
Kostenlos starten →